The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.
- First select the CSR Section, then a Table/Figure from that section.
- Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.
To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 528 KB) and Technical Notes (PDF, 794 KB) pages.
Download and Print: Download Printer-friendly PDF Download data
Figure 13.2
Figure 13.2
SEER Observed Incidence Rates a
Lymphocytic and Myeloid Leukemia (Acute and Chronic), by Sex
- Rates per 100,000 for Observed SEER Incidence, All Races, Male, 1975-2015, All Ages
- Rates per 100,000 for Observed SEER Incidence, All Races, Female, 1975-2015, All Ages
- Rates per 100,000 for Observed SEER Incidence, All Races, Male, 1975-2015, All Ages
- Rates per 100,000 for Observed SEER Incidence, All Races, Female, 1975-2015, All Ages
Rates per 100,000 for Observed SEER Incidence, All Races, Male, 1975-2015, All Ages
| Year | Chronic Lymphocytic Leukemia | Chronic Lymphocytic Leukemia Modeled (from Joinpoint) | Acute Lymphocytic Leukemia | Acute Lymphocytic Leukemia Modeled (from Joinpoint) |
|---|---|---|---|---|
| 1975 | 5.9 | 6.2 | 1.1 | 1.2 |
| 1976 | 6.8 | 6.2 | 1.3 | 1.2 |
| 1977 | 5.7 | 6.2 | 1.3 | 1.2 |
| 1978 | 5.9 | 6.2 | 1.2 | 1.3 |
| 1979 | 5.7 | 6.2 | 1.2 | 1.3 |
| 1980 | 6.3 | 6.2 | 1.4 | 1.3 |
| 1981 | 6.3 | 6.2 | 1.3 | 1.4 |
| 1982 | 6.1 | 6.2 | 1.5 | 1.4 |
| 1983 | 6.4 | 6.2 | 1.5 | 1.5 |
| 1984 | 6.3 | 6.3 | 1.5 | 1.5 |
| 1985 | 6.2 | 6.3 | 1.5 | 1.6 |
| 1986 | 6.3 | 6.3 | 1.7 | 1.6 |
| 1987 | 6.8 | 6.3 | 1.5 | 1.7 |
| 1988 | 6.5 | 6.3 | 1.8 | 1.7 |
| 1989 | 6.4 | 6.3 | 1.8 | 1.8 |
| 1990 | 6.3 | 6.3 | 1.8 | 1.8 |
| 1991 | 6.2 | 6.3 | 1.7 | 1.7 |
| 1992 | 6.8 | 6.3 | 1.6 | 1.6 |
| 1993 | 6.2 | 6.3 | 1.4 | 1.5 |
| 1994 | 6.2 | 6.3 | 1.5 | 1.6 |
| 1995 | 6.4 | 6.3 | 1.8 | 1.6 |
| 1996 | 6.4 | 6.3 | 1.6 | 1.6 |
| 1997 | 6.1 | 6.3 | 1.5 | 1.6 |
| 1998 | 6.0 | 6.3 | 1.6 | 1.6 |
| 1999 | 6.1 | 6.3 | 1.5 | 1.6 |
| 2000 | 6.6 | 6.6 | 1.5 | 1.6 |
| 2001 | 7.4 | 6.9 | 1.7 | 1.6 |
| 2002 | 7.3 | 7.3 | 1.8 | 1.6 |
| 2003 | 7.5 | 7.6 | 1.7 | 1.7 |
| 2004 | 7.7 | 8.0 | 1.7 | 1.7 |
| 2005 | 7.8 | 7.9 | 1.9 | 1.7 |
| 2006 | 7.7 | 7.8 | 1.6 | 1.7 |
| 2007 | 7.6 | 7.7 | 1.7 | 1.7 |
| 2008 | 7.5 | 7.6 | 1.8 | 1.7 |
| 2009 | 7.6 | 7.6 | 1.6 | 1.7 |
| 2010 | 7.9 | 7.5 | 1.6 | 1.7 |
| 2011 | 7.6 | 7.4 | 1.9 | 1.7 |
| 2012 | 7.2 | 7.3 | 1.5 | 1.8 |
| 2013 | 7.3 | 7.2 | 1.8 | 1.8 |
| 2014 | 7.7 | 7.2 | 1.8 | 1.8 |
| 2015 | 7.0 | 7.1 | 1.7 | 1.8 |
| 2016 | 6.8 | 7.0 | 1.9 | 1.8 |
| 2017 | 6.7 | 6.9 | 1.9 | 1.8 |
Rates per 100,000 for Observed SEER Incidence, All Races, Female, 1975-2015, All Ages
| Year | Chronic Lymphocytic Leukemia | Chronic Lymphocytic Leukemia Modeled (from Joinpoint) | Acute Lymphocytic Leukemia | Acute Lymphocytic Leukemia Modeled (from Joinpoint) |
|---|---|---|---|---|
| 1975 | 3.3 | 3.2 | 0.8 | 0.9 |
| 1976 | 3.1 | 3.2 | 0.9 | 1.0 |
| 1977 | 3.1 | 3.2 | 0.9 | 1.0 |
| 1978 | 3.4 | 3.2 | 0.8 | 1.0 |
| 1979 | 2.9 | 3.2 | 0.9 | 1.0 |
| 1980 | 3.3 | 3.2 | 0.9 | 1.0 |
| 1981 | 2.9 | 3.2 | 1.2 | 1.0 |
| 1982 | 3.0 | 3.2 | 1.0 | 1.0 |
| 1983 | 3.1 | 3.2 | 1.1 | 1.0 |
| 1984 | 3.1 | 3.2 | 1.2 | 1.0 |
| 1985 | 3.3 | 3.2 | 1.1 | 1.0 |
| 1986 | 3.2 | 3.2 | 1.0 | 1.1 |
| 1987 | 3.1 | 3.2 | 1.2 | 1.1 |
| 1988 | 3.1 | 3.2 | 1.1 | 1.1 |
| 1989 | 3.5 | 3.2 | 1.4 | 1.1 |
| 1990 | 3.4 | 3.2 | 1.2 | 1.1 |
| 1991 | 3.4 | 3.2 | 1.1 | 1.1 |
| 1992 | 3.2 | 3.2 | 1.1 | 1.1 |
| 1993 | 3.2 | 3.2 | 1.1 | 1.1 |
| 1994 | 3.5 | 3.2 | 0.9 | 1.2 |
| 1995 | 3.2 | 3.2 | 1.2 | 1.2 |
| 1996 | 3.6 | 3.2 | 1.2 | 1.2 |
| 1997 | 3.3 | 3.3 | 1.2 | 1.2 |
| 1998 | 3.0 | 3.3 | 1.3 | 1.2 |
| 1999 | 2.8 | 3.3 | 1.1 | 1.2 |
| 2000 | 3.3 | 3.4 | 1.3 | 1.2 |
| 2001 | 3.8 | 3.5 | 1.3 | 1.3 |
| 2002 | 3.6 | 3.6 | 1.2 | 1.3 |
| 2003 | 3.8 | 3.8 | 1.2 | 1.3 |
| 2004 | 4.0 | 3.9 | 1.4 | 1.3 |
| 2005 | 3.7 | 4.1 | 1.3 | 1.3 |
| 2006 | 4.5 | 4.2 | 1.3 | 1.3 |
| 2007 | 3.8 | 4.1 | 1.4 | 1.3 |
| 2008 | 4.1 | 4.1 | 1.1 | 1.4 |
| 2009 | 3.9 | 4.0 | 1.3 | 1.4 |
| 2010 | 4.0 | 3.9 | 1.4 | 1.4 |
| 2011 | 4.1 | 3.9 | 1.7 | 1.4 |
| 2012 | 3.9 | 3.8 | 1.4 | 1.4 |
| 2013 | 3.7 | 3.8 | 1.5 | 1.4 |
| 2014 | 3.6 | 3.7 | 1.4 | 1.4 |
| 2015 | 3.7 | 3.6 | 1.3 | 1.5 |
| 2016 | 3.3 | 3.6 | 1.5 | 1.5 |
| 2017 | 3.6 | 3.5 | 1.4 | 1.5 |
Rates per 100,000 for Observed SEER Incidence, All Races, Male, 1975-2015, All Ages
| Year | Chronic Myeloid Leukemia | Chronic Myeloid Leukemia Modeled (from Joinpoint) | Acute Myeloid Leukemia | Acute Myeloid Leukemia Modeled (from Joinpoint) |
|---|---|---|---|---|
| 1975 | 2.9 | 2.3 | 4.2 | 4.4 |
| 1976 | 2.5 | 2.3 | 4.4 | 4.3 |
| 1977 | 2.1 | 2.3 | 4.2 | 4.3 |
| 1978 | 2.3 | 2.3 | 4.4 | 4.3 |
| 1979 | 2.5 | 2.3 | 4.0 | 4.2 |
| 1980 | 2.1 | 2.3 | 4.1 | 4.2 |
| 1981 | 2.0 | 2.3 | 4.0 | 4.2 |
| 1982 | 2.2 | 2.3 | 4.8 | 4.1 |
| 1983 | 2.2 | 2.3 | 4.2 | 4.1 |
| 1984 | 2.4 | 2.3 | 4.1 | 4.1 |
| 1985 | 2.8 | 2.4 | 4.1 | 4.1 |
| 1986 | 2.2 | 2.4 | 3.9 | 4.0 |
| 1987 | 2.3 | 2.4 | 4.0 | 4.0 |
| 1988 | 2.5 | 2.4 | 3.8 | 4.0 |
| 1989 | 2.2 | 2.4 | 4.0 | 3.9 |
| 1990 | 2.5 | 2.4 | 3.9 | 3.9 |
| 1991 | 2.4 | 2.4 | 3.9 | 3.9 |
| 1992 | 2.2 | 2.4 | 3.8 | 4.0 |
| 1993 | 2.5 | 2.4 | 4.3 | 4.1 |
| 1994 | 2.5 | 2.4 | 4.1 | 4.2 |
| 1995 | 2.6 | 2.4 | 4.2 | 4.3 |
| 1996 | 2.4 | 2.4 | 4.3 | 4.4 |
| 1997 | 2.7 | 2.4 | 4.6 | 4.5 |
| 1998 | 1.9 | 2.4 | 4.9 | 4.7 |
| 1999 | 2.5 | 2.4 | 4.5 | 4.8 |
| 2000 | 2.3 | 2.4 | 4.9 | 4.9 |
| 2001 | 2.4 | 2.4 | 4.9 | 4.8 |
| 2002 | 2.1 | 2.4 | 4.6 | 4.6 |
| 2003 | 2.2 | 2.4 | 4.5 | 4.5 |
| 2004 | 2.6 | 2.4 | 4.1 | 4.4 |
| 2005 | 2.3 | 2.4 | 4.3 | 4.2 |
| 2006 | 2.4 | 2.4 | 4.1 | 4.1 |
| 2007 | 2.3 | 2.4 | 4.4 | 4.3 |
| 2008 | 2.4 | 2.5 | 4.7 | 4.5 |
| 2009 | 2.4 | 2.5 | 4.4 | 4.8 |
| 2010 | 2.5 | 2.5 | 5.4 | 5.0 |
| 2011 | 2.6 | 2.5 | 5.1 | 5.3 |
| 2012 | 2.4 | 2.5 | 5.6 | 5.5 |
| 2013 | 2.6 | 2.5 | 5.4 | 5.5 |
| 2014 | 2.6 | 2.5 | 5.3 | 5.4 |
| 2015 | 2.4 | 2.5 | 5.2 | 5.4 |
| 2016 | 2.7 | 2.5 | 5.5 | 5.4 |
| 2017 | 2.5 | 2.5 | 5.4 | 5.3 |
Rates per 100,000 for Observed SEER Incidence, All Races, Female, 1975-2015, All Ages
| Year | Chronic Myeloid Leukemia | Chronic Myeloid Leukemia Modeled (from Joinpoint) | Acute Myeloid Leukemia | Acute Myeloid Leukemia Modeled (from Joinpoint) |
|---|---|---|---|---|
| 1975 | 1.3 | 1.4 | 3.0 | 2.9 |
| 1976 | 1.6 | 1.4 | 2.9 | 2.9 |
| 1977 | 1.4 | 1.4 | 3.1 | 2.8 |
| 1978 | 1.3 | 1.4 | 2.7 | 2.8 |
| 1979 | 1.4 | 1.4 | 2.8 | 2.8 |
| 1980 | 1.5 | 1.4 | 2.4 | 2.7 |
| 1981 | 1.4 | 1.4 | 2.7 | 2.7 |
| 1982 | 1.4 | 1.4 | 2.6 | 2.7 |
| 1983 | 1.3 | 1.4 | 2.5 | 2.6 |
| 1984 | 1.2 | 1.4 | 2.7 | 2.6 |
| 1985 | 1.4 | 1.4 | 2.9 | 2.6 |
| 1986 | 1.3 | 1.4 | 2.4 | 2.5 |
| 1987 | 1.6 | 1.4 | 2.5 | 2.5 |
| 1988 | 1.5 | 1.4 | 2.5 | 2.6 |
| 1989 | 1.3 | 1.4 | 2.6 | 2.6 |
| 1990 | 1.2 | 1.4 | 2.4 | 2.7 |
| 1991 | 1.5 | 1.4 | 2.9 | 2.7 |
| 1992 | 1.5 | 1.4 | 2.8 | 2.8 |
| 1993 | 1.5 | 1.4 | 2.8 | 2.8 |
| 1994 | 1.4 | 1.4 | 3.0 | 2.9 |
| 1995 | 1.4 | 1.4 | 3.3 | 3.0 |
| 1996 | 1.4 | 1.4 | 2.9 | 3.0 |
| 1997 | 1.3 | 1.3 | 2.8 | 3.1 |
| 1998 | 1.4 | 1.3 | 3.2 | 3.1 |
| 1999 | 1.3 | 1.3 | 3.2 | 3.2 |
| 2000 | 1.4 | 1.3 | 3.4 | 3.3 |
| 2001 | 1.4 | 1.3 | 3.4 | 3.2 |
| 2002 | 1.3 | 1.3 | 3.0 | 3.2 |
| 2003 | 1.2 | 1.3 | 3.0 | 3.1 |
| 2004 | 1.2 | 1.3 | 2.9 | 3.1 |
| 2005 | 1.3 | 1.3 | 3.2 | 3.1 |
| 2006 | 1.4 | 1.3 | 3.2 | 3.0 |
| 2007 | 1.2 | 1.4 | 3.0 | 3.0 |
| 2008 | 1.4 | 1.4 | 3.2 | 3.1 |
| 2009 | 1.3 | 1.4 | 3.1 | 3.2 |
| 2010 | 1.4 | 1.4 | 3.4 | 3.4 |
| 2011 | 1.5 | 1.4 | 3.5 | 3.5 |
| 2012 | 1.6 | 1.4 | 3.8 | 3.7 |
| 2013 | 1.4 | 1.5 | 3.8 | 3.8 |
| 2014 | 1.5 | 1.5 | 3.7 | 3.7 |
| 2015 | 1.5 | 1.5 | 3.6 | 3.6 |
| 2016 | 1.6 | 1.5 | 3.5 | 3.6 |
| 2017 | 1.4 | 1.6 | 3.5 | 3.5 |
Footnotes:
a Source: SEER 9 areas. Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103).
Regression lines and APCs are calculated using the Joinpoint Regression Program Version 4.8, April 2020, National Cancer Institute.
Page Navigation: << Previous Next >>
The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.